Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
CRYPTO FLOW(08198): Zhu Hehua will retire as an independent non-executive director.
HOMELAND ITL (03798) spent HK$170,200 to repurchase 126,000 shares on April 22nd.
MONGOL MINING (00975) spent HKD 1.9793 million on April 22 to repurchase 195,000 shares.
CRYPTO FLOW(08198): Zhu Hehua will retire as an independent non-executive director.
HOMELAND ITL (03798) spent HK$170,200 to repurchase 126,000 shares on April 22nd.
MONGOL MINING (00975) spent HKD 1.9793 million on April 22 to repurchase 195,000 shares.
RECOMMEND
DeepSeek’s $10 Billion Valuation Financing Rumor And Four Layers Of Logical Judgment
21/04/2026
48 Hours Witness AI’s New Battlefield: Alibaba Joins, Tencent Open Sources, Manycore Tech Lists — Has The World Model Reached Its ChatGPT Moment?
21/04/2026
Public Fund Giants Reverse Course With Heavy Hong Kong IPO Cornerstone Allocations Exceeding HK$2.2 Billion Year‑To‑Date
21/04/2026
